Weizhi Xu
- Oncology top 10%
- Cancer Research
- Surgery
- Radiology, Nuclear Medicine and Imaging
- Cellular and Molecular Neuroscience
- Co-authors
- Haojun ChenYizhen PangLong SunTinghua MengHua WuLiang ZhaoXiaohong ChenJingjing Zhang
- Topics
- Peptidase Inhibition and Analysis (17 papers)Protease and Inhibitor Mechanisms (12 papers)Radiopharmaceutical Chemistry and Applications (6 papers)
- Partner nations
- ChinaSingaporeUnited States
In The Last Decade
Weizhi Xu
20 papers receiving 322 citations
Peers
Comparison fields: 5 of 37
- Oncology 283
- Cancer Research 115
- Surgery 108
- Radiology, Nuclear Medicine and Imaging 105
- Cellular and Molecular Neuroscience 59
Countries citing papers authored by Weizhi Xu
This map shows the geographic impact of Weizhi Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weizhi Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weizhi Xu more than expected).
Fields of papers citing papers by Weizhi Xu
This network shows the impact of papers produced by Weizhi Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weizhi Xu. The network helps show where Weizhi Xu may publish in the future.
Co-authorship network of co-authors of Weizhi Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Weizhi Xu. A scholar is included among the top collaborators of Weizhi Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weizhi Xu. Weizhi Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 13 | |
| 3 | 1 | |
| 4 | 6 | |
| 5 | 56 | |
| 6 | 2 | |
| 7 | 24 | |
| 8 | 18 | |
| 9 | 5 | |
| 10 | 2 | |
| 11 | 5 | |
| 12 | 3 | |
| 13 | 40 | |
| 14 | 10 | |
| 15 | 39 | |
| 16 | 3 | |
| 17 | 71 | |
| 18 | 2 | |
| 19 | 12 | |
| 20 | 8 |
About Weizhi Xu
Weizhi Xu is a scholar working on Cancer Research, Oncology and Cellular and Molecular Neuroscience, having authored 20 papers that have together received 324 indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (17 papers), Protease and Inhibitor Mechanisms (12 papers) and Radiopharmaceutical Chemistry and Applications (6 papers). The work is most often cited by research in Oncology (283 citations), Cancer Research (115 citations) and Radiology, Nuclear Medicine and Imaging (105 citations). Weizhi Xu has collaborated with scholars based in China, Singapore and United States. Frequent co-authors include Haojun Chen, Yizhen Pang, Long Sun, Tinghua Meng, Hua Wu, Liang Zhao, Xiaohong Chen, Jingjing Zhang, Qin Lin and Qihang Shang. Their work appears in journals such as Clinical Cancer Research, Theranostics and Journal of Nuclear Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.